Fabry disease (FD) is an X-linked lysosomal storage disorder caused by α-galactosidase A (α-GAL) deficiency, resulting in progressive accumulation of globotriaosylceramide and related glycosphingolipids, leading to progressive organ damage (including the heart, kidney, and brain).The GLA variant c.427G > A p.(Ala143Thr) is currently classified as a “variant of uncertain significance” (VUS). There is no consensus about this variant’s significance in the literature and it remains controversial in non-classical FD.We generated a human induced pluripotent stem cell (hiPSC) line derived from dermal fibroblasts of a 64-year-old hemizygous man carrying the p.(Ala143Thr) variant, using an RNA-based reprogramming method.
Generation of a human-induced pluripotent stem cell (hiPSC) line as a cellular model of Fabry disease from a patient carrying the p.A143T variant in the GLA gene (AOUMEYi005-A) / Rinaldi, M., Feo, F., Falliano, S., Giunti, L., Calamai, M., Pantaleo, M., Peron, A., Daniotti, M., Procopio, E., Guerrini, R., Morrone, A., Tonin, R.. - In: STEM CELL RESEARCH. - ISSN 1876-7753. - STAMPA. - 95:(2026), pp. 104058.0-104058.0. [10.1016/j.scr.2026.104058]
Generation of a human-induced pluripotent stem cell (hiPSC) line as a cellular model of Fabry disease from a patient carrying the p.A143T variant in the GLA gene (AOUMEYi005-A)
Rinaldi, Marina;Feo, Federica;Calamai, Martino;Pantaleo, Marilena;Peron, Angela;Daniotti, Marta;Procopio, Elena;Guerrini, Renzo;Morrone, Amelia;Tonin, Rodolfo
2026
Abstract
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by α-galactosidase A (α-GAL) deficiency, resulting in progressive accumulation of globotriaosylceramide and related glycosphingolipids, leading to progressive organ damage (including the heart, kidney, and brain).The GLA variant c.427G > A p.(Ala143Thr) is currently classified as a “variant of uncertain significance” (VUS). There is no consensus about this variant’s significance in the literature and it remains controversial in non-classical FD.We generated a human induced pluripotent stem cell (hiPSC) line derived from dermal fibroblasts of a 64-year-old hemizygous man carrying the p.(Ala143Thr) variant, using an RNA-based reprogramming method.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



